Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

This study is open to males and non-pregnant females, 12 years of age and over, with
clinical signs and symptoms of tinea pedis consisting of at least moderate erythema,
moderate scaling, mild pruritus, a positive screening KOH, and a positive culture.Subjects
will be evaluated at Day 1 (baseline), Week 2, Week 4, and Week 6 (follow-up). Adverse
events, concomitant medications,and study drug compliance will be reviewed at each visit.
Efficacy assessments will include KOH and culture evaluations, clinical signs/symptoms
(erythema, scaling, pruritus), and Investigator's Global Assessment.